LiT-Met is a five-year research project funded under the Horizon Europe programme, bringing together 20 partners from across Europe. The project is coordinated by the Alma Mater Studiorum – Università di Bologna and unites a multidisciplinary consortium of clinicians, researchers, patient representatives, and innovation experts.
The project's central aim is to generate robust scientific evidence on the role of liver transplantation as a life-extending treatment option for patients affected by borderline resectable colorectal liver metastases (CRLM). Over its 60-month duration, LiT-Met will work towards harmonised clinical guidelines across Europe, improved criteria for patient selection, more equitable access to treatment, and ultimately better outcomes for patients facing this condition.
At the heart of the project lies a collaborative, cross-disciplinary approach: by combining clinical expertise, scientific research, and the direct involvement of patient representatives, LiT-Met seeks to translate scientific innovation into concrete benefits for clinical practice, sharing its progress, discoveries, and impact with the wider community as the project advances.
